Nothing Special   »   [go: up one dir, main page]

DK1212119T3 - Anvendelse af cyamemazin ved behandling af brat seponering af benzodiazepiner - Google Patents

Anvendelse af cyamemazin ved behandling af brat seponering af benzodiazepiner

Info

Publication number
DK1212119T3
DK1212119T3 DK00956565T DK00956565T DK1212119T3 DK 1212119 T3 DK1212119 T3 DK 1212119T3 DK 00956565 T DK00956565 T DK 00956565T DK 00956565 T DK00956565 T DK 00956565T DK 1212119 T3 DK1212119 T3 DK 1212119T3
Authority
DK
Denmark
Prior art keywords
treatment
cyamemazine
benzodiazepines
abrupt discontinuation
abrupt
Prior art date
Application number
DK00956565T
Other languages
English (en)
Inventor
Alche-Biree Francoise D
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1212119T3 publication Critical patent/DK1212119T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK00956565T 1999-08-13 2000-07-28 Anvendelse af cyamemazin ved behandling af brat seponering af benzodiazepiner DK1212119T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910472A FR2797399B1 (fr) 1999-08-13 1999-08-13 Utilisation de la cyamemazine dans le traitement du sevrage aux benzodiazepines
PCT/FR2000/002186 WO2001012265A1 (fr) 1999-08-13 2000-07-28 Utilisation de la cyamemazine dans le traitement du sevrage brutal aux benzodiazepines

Publications (1)

Publication Number Publication Date
DK1212119T3 true DK1212119T3 (da) 2004-06-21

Family

ID=9549128

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00956565T DK1212119T3 (da) 1999-08-13 2000-07-28 Anvendelse af cyamemazin ved behandling af brat seponering af benzodiazepiner

Country Status (12)

Country Link
US (1) US6534500B2 (da)
EP (1) EP1212119B1 (da)
JP (1) JP5078209B2 (da)
AT (1) ATE262362T1 (da)
AU (1) AU6846300A (da)
CA (1) CA2381354C (da)
DE (1) DE60009315T2 (da)
DK (1) DK1212119T3 (da)
ES (1) ES2214305T3 (da)
FR (1) FR2797399B1 (da)
PT (1) PT1212119E (da)
WO (1) WO2001012265A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1626727B1 (en) * 2003-02-07 2008-12-31 Aventis Pharmaceuticals Inc. Use of 2-cyano-10- (2-methyl-3- (methylamino)- propyl) phenothiazine or a pharmaceutically acceptable salt thereof as a medicament
FR2850871B1 (fr) 2003-02-07 2006-07-14 Aventis Pharma Sa Application du 2-cyano-10-(2-methyl-3-(methylamino)propyl) phenothiazine ou un sel pharmaceutiquement acceptable comme medicament
US7855196B2 (en) * 2005-08-22 2010-12-21 Pierre Mainville Composition comprising a benzodiazepine agonist and a benzodiazepine antagonist
DE102011078999A1 (de) 2011-07-12 2013-01-17 Carl Zeiss Sms Gmbh Verfahren und Vorrichtung zur Positionsbestimmung von Strukturen auf einer Maske für die Mikrolithographie
DE102013101445B9 (de) 2013-02-14 2022-01-05 Carl Zeiss Smt Gmbh Verfahren zur Ermittlung von Verzeichnungseigenschaften eines optischen Systems in einer Messvorrichtung für die Mikrolithographie
DE102013106320B9 (de) 2013-06-18 2021-07-01 Carl Zeiss Smt Gmbh Verfahren zur Ermittlung von Verzeichnungseigenschaften eines optischen Systems in einer Messvorrichtung für die Mikrolithographie
DE102013107976B4 (de) 2013-07-25 2016-07-28 Carl Zeiss Sms Gmbh Positionsbestimmung von Strukturen auf einer Maske für die Mikrolithographie

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE552557A (da) * 1955-11-15
US4666903A (en) * 1985-08-13 1987-05-19 Yale University Novel use of benzodiazepine antagonist
FR2654621B1 (fr) 1989-11-22 1994-09-23 Esteve Labor Dr Inhibition du syndrome d'abstinence.
EP0591434A4 (en) * 1991-06-26 1994-09-14 Sepracor Inc Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
TW587938B (en) * 1997-03-27 2004-05-21 Akzo Nobel Nv Pharmaceutical composition for the treatment and/or prophylaxis of psychotic disorder
EP0971721A1 (en) 1997-04-02 2000-01-19 Bioniche Inc. Use of bacterial cell wall extract for preventing, treating, or eliminating a protozoal or parasitic disease

Also Published As

Publication number Publication date
US6534500B2 (en) 2003-03-18
FR2797399A1 (fr) 2001-02-16
ES2214305T3 (es) 2004-09-16
EP1212119B1 (fr) 2004-03-24
PT1212119E (pt) 2004-07-30
WO2001012265A1 (fr) 2001-02-22
JP2003507352A (ja) 2003-02-25
CA2381354C (en) 2008-12-30
CA2381354A1 (fr) 2001-02-22
ATE262362T1 (de) 2004-04-15
FR2797399B1 (fr) 2002-10-18
JP5078209B2 (ja) 2012-11-21
US20020183332A1 (en) 2002-12-05
EP1212119A1 (fr) 2002-06-12
DE60009315T2 (de) 2005-02-17
DE60009315D1 (de) 2004-05-13
AU6846300A (en) 2001-03-13

Similar Documents

Publication Publication Date Title
IL152916A0 (en) Heteroaryl-phenyl heterobicyclic factor xa inhibitors
ATE355278T1 (de) Isochinolinon derivate als parp inhibitoren
GB0031088D0 (en) Medicaments
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
BR9710994A (pt) Derivados anticonvulsivos úteis no tratamento de obesidade.
GB9917406D0 (en) Compounds
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
MXPA03007140A (es) Derivados de carbolina.
MY142948A (en) Benzophenones as inhibitors of reverse transcriptase
HUP0101333A3 (en) Diazepan derivatives and their salts, pharmaceutical compositions containing the same
ATE234840T1 (de) 1-aminotriazolo 4,3-a chinazolin-5-one und/oder - thione inhibitoren von phosphodiesterasen iv
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
DK1212119T3 (da) Anvendelse af cyamemazin ved behandling af brat seponering af benzodiazepiner
DK1150704T3 (da) Melagatran til behandling af betændelse
ZA200107143B (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders.
PT1152756E (pt) Derivados de anticonvulsivo uteis no tratamento do autismo
CY1108053T1 (el) Ενωση της κυαμεμαζινης και ενος ατυπου νευροληπτικου
PT1000046E (pt) Derivados de piperazina activos no trato urinario inferior
AU1604001A (en) Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects
NO20013459D0 (no) Anvendelse av agiotensin II reseptorantagonister ved behandling av akutt myokardinfarkt
BR9914722A (pt) Derivados de anticonvulsivo úteis no tratamento de dependência, vìcio e abuso do álcool
YU87501A (sh) Farmaceutski kompleksi
PT1273556E (pt) Estacao de tratamento simbiotico de aguas residuais.
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
HK1042039A1 (en) Use of phanquinone for the treatment or preventionof memory impairment.